Your browser doesn't support javascript.
loading
Corrigendum to - "Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques" [eBioMedicine 58(2020) 102894].
Massud, Ivana; Ruone, Susan; Zlotorzynska, Maria; Haaland, Richard; Mills, Patrick; Cong, Mian-Er; Kelley, Kristen; Johnson, Ryan; Holder, Angela; Dinh, Chuong; Khalil, George; Pan, Yi; Kelley, Colleen F; Sanchez, Travis; Heneine, Walid; García-Lerma, J Gerardo.
Afiliação
  • Massud I; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Ruone S; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Zlotorzynska M; Rollins School of Public Health, Emory University, Atlanta, GA, United States.
  • Haaland R; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Mills P; Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Cong ME; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Kelley K; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Johnson R; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Holder A; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Dinh C; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Khalil G; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Pan Y; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Kelley CF; Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, GA, United States.
  • Sanchez T; Rollins School of Public Health, Emory University, Atlanta, GA, United States.
  • Heneine W; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • García-Lerma JG; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: jng5@cdc.gov.
EBioMedicine ; 101: 105014, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38354533
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EBioMedicine Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EBioMedicine Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos